In this study, we revealed that the impaired SUMOylation of FoxA1 promoted its ubiquitylation and degradation, which transcriptionally inhibited Sirt6 and subsequently restrained Pparα-mediated fatty acid β-oxidation, thereby aggravating NAFLD. Here, FOXA1 is linked to metabolic dysfunction-associated steatotic liver disease.